申请人:Daiichi Sankyo Company, Limited
公开号:US20220106324A1
公开(公告)日:2022-04-07
A compound that inhibits interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity is provided. The present invention provides a dispiropyrrolidine derivative represented by the following formula (1), which has various substituents, inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity, wherein R
1
, R
2
, R
3
, ring A, and ring B in formula (1) respectively have the same meanings as defined in the specification.